News outlets report on the testing of an experimental dengue vaccine, which the maker says could be available next year.

Reuters: Sanofi says first dengue vaccine may be available in second half of 2015
“Sanofi said on Monday that a late-stage clinical study showed that its dengue vaccine candidate met its main goal and was highly effective against severe cases of the disease. The French drugmaker’s Sanofi Pasteur division intends to file for registration for the vaccine in several endemic countries next year, it said in a statement…” (Regan, 11/3).

Times of India: Dengue vaccine tested on Indian adults, found safe
“…In an exclusive interview to TOI, the vaccine makers Sanofi Pasteur revealed that their first study of the vaccine on Indian adults (aged 18-45 years) across five sites in India — Delhi, Ludhiana, Bangalore, Pune, and Kolkata — found the vaccine ‘safe and immunogenic in Indian adults’ with results comparable to other clinical studies in Asia…” (Sinha, 11/2).